Page 214 - Read Online
P. 214

Page 8 of 10                                                     Sticchi et al. Vessel Plus 2018;2:23  I  http://dx.doi.org/10.20517/2574-1209.2018.47

               in endovascular techniques allow the operators to predict, face promptly and overcome vascular access com-
               plications.


               Whatever the access and the chosen strategy, a discerning management of the access site in structural proce-
               dures, such as TAVI, allows to protect the patient from a high morbidity and mortality.



               DECLARATIONS
               Authors’ contributions
               Planning and writing: Sticchi A
               Writing: Bressi E
               Revision of the manuscript: Nusca A, Di Sciascio G

               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               None.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2018.



               REFERENCES
               1.   Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R,
                   Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL; ESC Scientific Document Group. 2017 ESC/
                   EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739-91.
               2.   Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chet-
                   cuti S, Gleason T, Heiser J, Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R,
                   Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP; SURTAVI Investigators. Surgical or transcath-
                   eter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017;376:1321-31.
               3.   Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 2009;53:1829-36.
               4.   Holmes DR, Jr, Mack MJ. Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foun-
                   dation and the Society of Thoracic Surgeons. Ann Thorac Surg 2011;92:380-9.
               5.   Willson AB, Webb JG, Labounty TM, Achenbach S, Moss R, Wheeler M, Thompson C, Min JK, Gurvitch R, Norgaard BL, Hague CJ,
                   Toggweiler S, Binder R, Freeman M, Poulter R, Poulsen S, Wood DA, Leipsic J. 3-dimensional aortic annular assessment by multide-
                   tector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a mul-
                   ticenter retrospective analysis. J Am Coll Cardiol 2012;59:1287-94.
               6.   Gilard M1, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E,
                   Lefevre T, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau
                   N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann
                   P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Van Belle E, Laskar M; FRANCE 2 Investigators. Registry of
                   transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366:1705-15.
               7.   Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B,
   209   210   211   212   213   214   215   216   217   218   219